Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...
In a major shift in its hardware strategy, OpenAI launched GPT-5.3-Codex-Spark, its first production AI model deployed on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results